Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
I don't make it my primary business to go against the trend. Sure, it can be pretty satisfying and certainly pays well to nail a turn in a major trend. But it's a tricky business that has left behind a graveyard of wannabe Heroes.
JC and I are generally on the same page about a lot of things, but this week our brains seem to be very in sync as we're writing about the same topics with a slightly different spin on each...
The All Star Charts team has been drawing attention to financials and banks recently, putting forth the idea that the broader markets likely will not rally without banks participating:
With U.S. Large-cap Indexes breaking out to new all-time highs, many are wondering when, and if, the Small-caps are ever going to catch up. The Dow Jones Industrial Average, S&P500 and Nasdaq100 have all taken out former highs and are currently in...
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in...
Since early July stocks in India have come under more selling pressure, with the Mid-Caps and Small-Cap indices falling roughly 10% and the large-cap Nifty 50 falling about 6%.
This has exacerbated the relative underperformance of India versus...
Financials are a big focus of ours right now. We can make a strong case that this is the most important sector in America. Traditionally, Industrials are the most positively correlated with the S&P500 and Technology is the largest sector by market...
There's an opportunity developing out on the farm -- everyone's favorite farming machinery (and apparel?) company is setting up for a big harvest. While investors should take notice, opportunistic trader hunters like us have spotted a way to get in/...
